Claudia Pinto Marques Souza de Oliveira


Country: Brazil


  1. Rabelo F, Stefano J, Cavaleiro A, Lima R, de Campos Mazo D, Carrilho F, et al. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population. Hepatobiliary Pancreat Dis Int. 2018;: pubmed publisher
    ..The presence of metabolic syndrome was associated with advanced degrees of fibrosis in NAFLD patients. ..
  2. request reprint
    Oliveira C, Alves V, Lima V, Stefano J, Debbas V, Sá S, et al. Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice. Biochem Pharmacol. 2007;74:290-7 pubmed
    ..Further studies are in progress to examine possible mechanisms and to develop SNAC as a possible therapy for human fatty liver disease. ..
  3. request reprint
    de Oliveira C, de Lima V, Simplicio F, Soriano F, de Mello E, de Souza H, et al. Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment. J Am Coll Nutr. 2008;27:299-305 pubmed
    ..Oral administration of SNAC markedly inhibited and reversed NASH induced by MCD and H diets in ob/ob mice. ..
  4. Siqueira E, Pereira L, Stefano J, Patente T, Cavaleiro A, Silva Vasconcelos L, et al. Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C. Eur J Med Res. 2015;20:45 pubmed publisher
  5. Willebrords J, Pereira I, Maes M, Crespo Yanguas S, Colle I, Van den Bossche B, et al. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res. 2015;59:106-25 pubmed publisher
    ..Furthermore, the current state-of-art regarding experimental biomarkers such as epigenetic, genetic, transcriptomic, proteomic and metabonomic biomarkers will be reviewed. ..
  6. Oliveira C, Stefano J. Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review. Clin Res Hepatol Gastroenterol. 2015;39 Suppl 1:S35-40 pubmed publisher
    ..These studies need a large number of well phenotyped cases and controls and certainly require national and international collaboration. ..
  7. Barbosa M, Zaninotto A, de Campos Mazo D, Pessôa M, de Oliveira C, Carrilho F, et al. Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin. BMC Gastroenterol. 2017;17:122 pubmed publisher
    ..016) and 28.6% 6 months after the end of treatment (p =?0.719). Eradication of HCV infection improved cognitive performance but did not affect the frequency of depressive symptoms at least in the short range. ..
  8. Oliveira C, Stefano J, Cavaleiro A, Zanella Fortes M, Vieira S, Rodrigues Lima V, et al. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2010;25:357-61 pubmed publisher
    ..These two polymorphisms could represent an additional factor for consideration in evaluating the risk of NAFLD progression. Further studies involving a larger population are necessary to confirm this notion. ..